Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 11, 2008, Pages 745-751

  Böhm, Felix ^a   Jensen, Jens ^a   Svane, Bertil ^a   Settergren, Magnus ^a   Pernow, John ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Blood flow; Endothelial dysfunction; Endothelin

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; SODIUM CHLORIDE; SUBSTANCE P;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; HEART CATHETERIZATION; HUMAN; INTRACORONARY INFUSION; PRIORITY JOURNAL; RECEPTOR BLOCKING;

AGED; AORTA, THORACIC; ATHEROSCLEROSIS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CAPILLARIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; HEART CATHETERIZATION; HUMANS; LIPIDS; MALE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 56449117834     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-081     Document Type: Article

References (28)

1. Barton, M., Haudenschild, C.C., d'Uscio, L.V., Shaw, S., Munter, K., and Luscher, T.F. 1998. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 95(24): 14367-14372. doi:10.1073/pnas.95.24.14367. PMID:9826706.
2. Böhm, F., and Pernow, J. 2007. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc. Res. 76(1): 8-18. doi:10.1016/j.cardiores.2007.06.004. PMID:17617392.
3. Böhm, F., Ahlborg, G., Johansson, B.L., Hansson, L.O., and Pernow, J. 2002a. Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22(4): 674-679. doi:10.1161/ 01.ATV.0000012804.63152.60. PMID:11950709.
4. Böhm, F., Ahlborg, G., and Pernow, J. 2002b. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. Clin. Sci. (Lond.), 102(3): 321-327. PMID:11869173.
5. Böhm, F., Johansson, B.L., Hedin, U., Alving, K., and Pernow, J. 2002c. Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. Atherosclerosis, 160(1): 215-222. doi:10.1016/S0021-9150(01)00564-0. PMID:11755940.
6. Böhm, F., Beltran, E., and Pernow, J. 2005. Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition. J. Intern. Med. 257: 263-271. doi:10.1111/j.1365-2796.2005.01448.x. PMID:15715683.
7. Böhm, F., Settergren, M., and Pernow, J. 2007. Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo. Atherosclerosis, 190(2): 408-415. doi:10.1016/j. atherosclerosis.2006.02.018. PMID:16527283.
8. Crossman, D.C., Larkin, S.W., Fuller, R.W., Davies, G.J., and Maseri, A. 1989. Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans. Circulation, 80(3): 475-484. PMID:2475277.
9. De Bruyne, B., Pijls, N.H., Smith, L., Wievegg, M., and Heyndrickx, G.R. 2001. Coronary thermodilution to assess flow reserve: experimental validation. Circulation, 104(17): 2003-2006. doi:10.1161/hc4201.099223. PMID:11673336.
10. Doucette, J.W., Corl, P.D., Payne, H.M., Flynn, A.E., Goto, M., Nassi, M., et al. 1992. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation, 85(5): 1899-1911. PMID:1572046.
11. Fearon, W.F., Farouque, H.M., Balsam, L.B., Caffarelli, A.D., Cooke, D.T., Robbins, R.C., et al. 2003. Comparison of coronary thermodilution and Doppler velocity for assessing coronary flow reserve. Circulation, 108(18): 2198-2200. doi:10.1161/01.CIR.0000099521.31396.9D. PMID:14568891.
12. A receptor blockade. Circ. Res. 89(11): 969-976. doi:10.1161/hh2301.100980. PMID:11717152.
13. Halcox, J.P., Nour, K.R., Zalos, G., and Quyyumi, A.A. 2007. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B. Hypertension, 49(5): 1134-1141. doi:10.1161/HYPERTENSIONAHA.106.083303.PMID:17353514.
14. Hemsén, A. 1991. Biochemical and functional characterization of endothelin peptides with special reference to vascular effects. Acta Physiol. Scand. Suppl. 602: 1-61. PMID:1659115.
15. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., and Chaudhuri, G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 84(24): 9265-9269. doi:10.1073/pnas.84.24.9265. PMID:2827174.
16. Iwasa, S., Fan, J., Shimokama, T., Nagata, M., and Watanabe, T. 1999. Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions: a possible role in atherogenesis. Atherosclerosis, 146: 93-100. doi:10.1016/S0021-9150(99)00134-3. PMID:10487491.
17. Kinlay, S., Behrendt, D., Wainstein, M., Beltrame, J., Fang, J.C., Creager, M.A., et al. 2001. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation, 104(10): 1114-1118. doi:10.1161/hc3501.095707. PMID:11535565.
18. Lerman, A., Edwards, B.S., Hallett, J.W., Heublein, D., Sandberg, S.M., and Burnett, J.C. 1991. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 325: 997-1001. PMID:1886637.
19. MacCarthy, P.A., Pegge, N.C., Prendergast, B.D., Shah, A.M., and Groves, P.H. 2001. The physiological role of endogenous endothelin in the regulation of human coronary vasomotor tone. J. Am. Coll. Cardiol. 37(1): 137-143. doi:10.1016/S0735-1097(00)01042-1. PMID:11153728.
20. Melikian, N., Kearney, M.T., Thomas, M.R., De Bruyne, B., Shah, A.M., and MacCarthy, P.A. 2007. A simple thermodilution technique to assess coronary endothelium-dependent microvascular function in humans: validation and comparison with coronary flow reserve. Eur. Heart J. 28: 2188-2194. doi:10.1093/eurheartj/ehm269. PMID:17644509.
21. Perticone, F., Ceravolo, R., Pujia, A., Ventura, G., Iacopino, S., Scozzafava, A., et al. 2001. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation, 104(2): 191-196. PMID:11447085.
22. Pijls, N.H., De Bruyne, B., Smith, L., Aarnoudse, W., Barbato, E., Bartunek, J., et al. 2002. Coronary thermodilution to assess flow reserve: validation in humans. Circulation, 105(21): 2482-2486. doi:10.1161/01.CIR.0000017199.09457.3D. PMID:12034653.
23. Reiber, J.H., and Serruys, P.W. (Editors). 1991. Quantitative coronary angiography. (Developments in cardiovascular medicine.) Kluwer Academic, Dordrecht, The Netherlands.
24. Schachinger, V., Britten, M.B., and Zeiher, A.M. 2000. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 101(16): 1899-1906. PMID:10779454.
25. Shemyakin, A., Böhm, F., Wagner, H., Efendic, S., Båvenholm, P., and Pernow, J. 2006. Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance. J. Cardiovasc. Pharmacol. 47(3): 385-390. PMID:16633080.
26. Sutherland, A.J., Nataatmadja, M.I., Walker, P.J., Cuttle, L., Garlick, R.B., and West, M.J. 2006. Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression. Circulation, 113(9): 1180-1188. doi:10.1161/CIRCULATIONAHA.105.582890. PMID:16505174.
27. Verma, S., Lovren, F., Dumont, A.S., Mather, K.J., Maitland, A., Kieser, T.M., et al. 2001. Endothelin receptor blockade improves endothelial function in human internal mammary arteries. Cardiovasc. Res. 49(1): 146-151. doi:10.1016/S0008-6363(00)00244-3. PMID:11121806.
28. Zeiher, A.M., Goebel, H., Schächinger, V., and Ihling, C. 1995. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. Circulation, 91: 941-947. PMID:7850978.